In the Journals

This feature offers timely executive summaries of the most relevant journals in rheumatology. Through peer “Perspectives,” full bibliographical information and links to the original journal abstract, In the Journals are a step wider and deeper than journal reviews health care professionals may be accustomed.

In the Journals

Early MRI response to RA therapy predicts long-term progression better than disease activity

November 5, 2019
MRI changes recorded as early as 1 month after the start of treatment for rheumatoid arthritis may be a better predictor of long-term radiographic…
In the Journals

Fibromyalgia linked to worse cognitive function, 'fibrofog'

November 5, 2019
Patients with fibromyalgia demonstrate worse objective and subjective cognitive function — sometimes called “fibrofog” —…
In the Journals

Patients with most SLE damage incur ninefold higher costs over a decade

November 4, 2019
Patients with the most damage related to systemic lupus erythematosus pay nearly nine times higher cumulative costs over a 10-year period compared…
In the Journals

Infrared thermography reliable in assessing children with Raynaud's phenomenon

November 4, 2019
Infrared thermography is both reliable and reproducible in identifying children with peripheral microvascular disturbances in Raynaud’s…
In the Journals

High RA disease activity increases risk for pain one year after arthroplasty

October 31, 2019
Higher rheumatoid arthritis disease activity at the time of total hip or knee arthroplasty is associated with an increased risk for worse pain and…
In the Journals

Parenchymal lung disease reported in systemic juvenile idiopathic arthritis

October 31, 2019
Acute digital clubbing was one clinical characteristic of a rare and potentially fatal lung disease recently observed in a cohort of patients with…
In the Journals

Secukinumab improves disease manifestations, QoL in PsA across phenotypes

October 31, 2019
Secukinumab is beneficial for patients with psoriatic arthritis across the spectrum of clinical phenotypes for the disease, according to findings…
In the JournalsPerspective

Price increases largely to blame for $3 billion spending hike on biologic DMARDs

October 30, 2019
Post-market drug price increases are responsible for as much as 57% of the $3 billion hike in Medicare Part D spending on biologic DMARDs from 2012…
In the Journals

Amniotic suspension allograft may be an effective nonoperative treatment for knee OA

October 30, 2019
Amniotic suspension allograft may be an effective nonoperative treatment of symptomatic knee osteoarthritis, according to recently published results…
In the Journals

Opportunistic infection risk highest for patients with polymyositis, dermatomyositis

October 30, 2019
Among systemic rheumatic diseases, the risk for opportunistic infection is highest among patients with polymyositis or dermatomyositis, followed by…